Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schmid

Showing results (671-680 of 733) with videos related to

Pageof 74
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2020
Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKDDominik Steubl, Markus P Schneider, Heike Meiselbach, et al.
Immunological Investigations|September 20, 2019
Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the DiseaseM Merle, D Fischbacher, A Liepert, et al.
Frontiers in Immunology|June 8, 2018
Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic MelanomaCarlos R Figueiredo, Ricardo A Azevedo, Sasha Mousdell, et al.
Urologic Oncology|May 15, 2017
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatinSebastian C Schmid, Anuja Sathe, Ferdinand Guerth, et al.
ACS Chemical Biology|January 24, 2007
A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)Erika Rosivatz, Jonathan G Matthews, Neil Q McDonald, et al.
Immunobiology|April 10, 2021
Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactionsM Merle, D Fischbacher, A Liepert, et al.
Bone Marrow Transplantation|March 2, 2011
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot studyC Schmid, M Schleuning, J Tischer, et al.
Applied and Environmental Microbiology|February 5, 2005
Propionate oxidation by and methanol inhibition of anaerobic ammonium-oxidizing bacteriaDidem Güven, Ana Dapena, Boran Kartal, et al.
BJU International|April 3, 2016
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapyMatthias M Heck, Markus A Thaler, Sebastian C Schmid, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Pageof 74

Showing results (671-680 of 733) with videos related to

Sort By:
Pageof 74
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2020
Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKDDominik Steubl, Markus P Schneider, Heike Meiselbach, et al.
Immunological Investigations|September 20, 2019
Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the DiseaseM Merle, D Fischbacher, A Liepert, et al.
Frontiers in Immunology|June 8, 2018
Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic MelanomaCarlos R Figueiredo, Ricardo A Azevedo, Sasha Mousdell, et al.
Urologic Oncology|May 15, 2017
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatinSebastian C Schmid, Anuja Sathe, Ferdinand Guerth, et al.
ACS Chemical Biology|January 24, 2007
A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)Erika Rosivatz, Jonathan G Matthews, Neil Q McDonald, et al.
Immunobiology|April 10, 2021
Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactionsM Merle, D Fischbacher, A Liepert, et al.
Bone Marrow Transplantation|March 2, 2011
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot studyC Schmid, M Schleuning, J Tischer, et al.
Applied and Environmental Microbiology|February 5, 2005
Propionate oxidation by and methanol inhibition of anaerobic ammonium-oxidizing bacteriaDidem Güven, Ana Dapena, Boran Kartal, et al.
BJU International|April 3, 2016
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapyMatthias M Heck, Markus A Thaler, Sebastian C Schmid, et al.
Bone Marrow Transplantation|July 28, 2009
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMTY Chalandon, J R Passweg, C Schmid, et al.
Pageof 74